BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 21152357)

  • 1. Estrogen promotes breast cancer cell survival in an inhibitor of apoptosis (IAP)-dependent manner.
    Stanculescu A; Bembinster LA; Borgen K; Bergamaschi A; Wiley E; Frasor J
    Horm Cancer; 2010 Jun; 1(3):127-35. PubMed ID: 21152357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitor of Apoptosis Protein-1 Regulates Tumor Necrosis Factor-Mediated Destruction of Intestinal Epithelial Cells.
    Grabinger T; Bode KJ; Demgenski J; Seitz C; Delgado ME; Kostadinova F; Reinhold C; Etemadi N; Wilhelm S; Schweinlin M; Hänggi K; Knop J; Hauck C; Walles H; Silke J; Wajant H; Nachbur U; W Wei-Lynn W; Brunner T
    Gastroenterology; 2017 Mar; 152(4):867-879. PubMed ID: 27889570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Up-Regulation of Glioma-Associated Oncogene Homolog 1 Expression by Serum Starvation Promotes Cell Survival in ER-Positive Breast Cancer Cells.
    Xu J; Huang G; Zhang Z; Zhao J; Zhang M; Wang Y; Liu Z; Lu J
    Cell Physiol Biochem; 2015; 36(5):1862-76. PubMed ID: 26182949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular determinants of Smac mimetic induced degradation of cIAP1 and cIAP2.
    Darding M; Feltham R; Tenev T; Bianchi K; Benetatos C; Silke J; Meier P
    Cell Death Differ; 2011 Aug; 18(8):1376-86. PubMed ID: 21331077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting inhibitor of apoptosis proteins in combination with ErbB antagonists in breast cancer.
    Foster FM; Owens TW; Tanianis-Hughes J; Clarke RB; Brennan K; Bundred NJ; Streuli CH
    Breast Cancer Res; 2009; 11(3):R41. PubMed ID: 19563669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. USP11-dependent selective cIAP2 deubiquitylation and stabilization determine sensitivity to Smac mimetics.
    Lee EW; Seong D; Seo J; Jeong M; Lee HK; Song J
    Cell Death Differ; 2015 Sep; 22(9):1463-76. PubMed ID: 25613375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overcoming cancer cell resistance to Smac mimetic induced apoptosis by modulating cIAP-2 expression.
    Petersen SL; Peyton M; Minna JD; Wang X
    Proc Natl Acad Sci U S A; 2010 Jun; 107(26):11936-41. PubMed ID: 20547836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of Potent SMAC Mimetics that Sensitize Cancer Cells to TNF Family-Induced Apoptosis.
    Welsh K; Milutinovic S; Ardecky RJ; Gonzalez-Lopez M; Ganji SR; Teriete P; Finlay D; Riedl S; Matsuzawa S; Pinilla C; Houghten R; Vuori K; Reed JC; Cosford ND
    PLoS One; 2016; 11(9):e0161952. PubMed ID: 27617834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of NgBR is highly associated with estrogen receptor alpha and survivin in breast cancer.
    Wang B; Zhao B; North P; Kong A; Huang J; Miao QR
    PLoS One; 2013; 8(11):e78083. PubMed ID: 24223763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 17β-estradiol regulates giant vesicle formation via estrogen receptor-alpha in human breast cancer cells.
    Wright PK; Jones SB; Ardern N; Ward R; Clarke RB; Sotgia F; Lisanti MP; Landberg G; Lamb R
    Oncotarget; 2014 May; 5(10):3055-65. PubMed ID: 24931391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LCL161 increases paclitaxel-induced apoptosis by degrading cIAP1 and cIAP2 in NSCLC.
    Yang C; Wang H; Zhang B; Chen Y; Zhang Y; Sun X; Xiao G; Nan K; Ren H; Qin S
    J Exp Clin Cancer Res; 2016 Sep; 35(1):158. PubMed ID: 27737687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A small molecule Smac-mimic compound induces apoptosis and sensitizes TRAIL- and etoposide-induced apoptosis in breast cancer cells.
    Bockbrader KM; Tan M; Sun Y
    Oncogene; 2005 Nov; 24(49):7381-8. PubMed ID: 16044155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Buthionine sulfoximine sensitizes antihormone-resistant human breast cancer cells to estrogen-induced apoptosis.
    Lewis-Wambi JS; Kim HR; Wambi C; Patel R; Pyle JR; Klein-Szanto AJ; Jordan VC
    Breast Cancer Res; 2008; 10(6):R104. PubMed ID: 19061505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smac mimetic Birinapant induces apoptosis and enhances TRAIL potency in inflammatory breast cancer cells in an IAP-dependent and TNF-α-independent mechanism.
    Allensworth JL; Sauer SJ; Lyerly HK; Morse MA; Devi GR
    Breast Cancer Res Treat; 2013 Jan; 137(2):359-71. PubMed ID: 23225169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progesterone receptor-B induction of BIRC3 protects endometrial cancer cells from AP1-59-mediated apoptosis.
    Neubauer NL; Ward EC; Patel P; Lu Z; Lee I; Blok LJ; Hanifi-Moghaddam P; Schink J; Kim JJ
    Horm Cancer; 2011 Jun; 2(3):170-81. PubMed ID: 21760855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Birinapant (TL32711), a bivalent SMAC mimetic, targets TRAF2-associated cIAPs, abrogates TNF-induced NF-κB activation, and is active in patient-derived xenograft models.
    Benetatos CA; Mitsuuchi Y; Burns JM; Neiman EM; Condon SM; Yu G; Seipel ME; Kapoor GS; Laporte MG; Rippin SR; Deng Y; Hendi MS; Tirunahari PK; Lee YH; Haimowitz T; Alexander MD; Graham MA; Weng D; Shi Y; McKinlay MA; Chunduru SK
    Mol Cancer Ther; 2014 Apr; 13(4):867-79. PubMed ID: 24563541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small-molecule SMAC mimetics as new cancer therapeutics.
    Bai L; Smith DC; Wang S
    Pharmacol Ther; 2014 Oct; 144(1):82-95. PubMed ID: 24841289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and regulation of retinoid-inducible gene 1 (RIG1) in breast cancer.
    Shyu RY; Chang SC; Yu JC; Hsu SJ; Chou JM; Lee MS; Jiang SY
    Anticancer Res; 2005; 25(3c):2453-60. PubMed ID: 16080475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrinsic mechanism of estradiol-induced apoptosis in breast cancer cells resistant to estrogen deprivation.
    Lewis JS; Meeke K; Osipo C; Ross EA; Kidawi N; Li T; Bell E; Chandel NS; Jordan VC
    J Natl Cancer Inst; 2005 Dec; 97(23):1746-59. PubMed ID: 16333030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Harmful effect of ERβ on BCRP-mediated drug resistance and cell proliferation in ERα/PR-negative breast cancer.
    Li W; Jia M; Qin X; Hu J; Zhang X; Zhou G
    FEBS J; 2013 Dec; 280(23):6128-40. PubMed ID: 24103091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.